Data showed that LINC00941 promoted cancer cells proliferation, while agomiR-877-3p or si-VEGFA reversed the accelerating effects of LINC00941 in NSCLC progression (Figure 6E). This evidence concerns the gene VEGFA and non-small cell lung carcinoma.